NCT03734315View on ClinicalTrials.gov

Routine Application of Ostenil® in Patients with Gonarthrosis

CompletedOBSERVATIONAL
Enrollment

115

Participants

Timeline

Start Date

January 8, 2019

Primary Completion Date

January 12, 2023

Study Completion Date

January 12, 2023

Conditions
Gonarthrosis
Interventions
DEVICE

Ostenil®

Ostenil® is a CE-certified viscoelastic solution for injection into the joint cavity, containing 1.0 % sodium hyaluronate from fermentation.

Trial Locations (6)

80331

Orthopädie am Altheimer Eck, München

Orthopädie München, München

Orthopädische Praxis am Isartor, München

80797

MVZ am Nordbad, München

80993

Orthopädische Praxis, München

81825

Orthopädisches Versorgungszentrum München-Ost, Munich

All Listed Sponsors
lead

TRB Chemedica AG

INDUSTRY

NCT03734315 - Routine Application of Ostenil® in Patients with Gonarthrosis | Biotech Hunter | Biotech Hunter